Arterial stiffness in patients with bipolar disorder

ArticleAçık Erişim

Özet

Objective: Bipolar disorder (BD) is an inflammatory and metabolic disease. The disease and the drugs used to treat it may affect cardiovascular disease (CVD) risk. The aim of this study is to investigate arterial stiffness in patients with BD and compare them with healthy controls. Methods: Thirty-nine patients with BD type I in remission and 39 healthy control subjects were included in the study. Carotid and femoral artery intima-media thickness (IMT) and arterial thickness parameters were measured by Doppler ultrasonography. Results: The elastic modulus value of the carotid artery was significantly higher in the patients than in the control group (p = 0.015). Although the IMT of both carotid and femoral artery was thicker in patients than in healthy control subjects, this difference was not statistically significant (p = 0.105; p = 0.391). There was a significant positive correlation between chlorpromazine equivalent dose and femoral elastic modulus value (p = 0.021, r = 0.539). There was a positive correlation between lithium equivalent dose and carotid compliance; a significant negative correlation between lithium equivalent dose and carotid elastic modulus was also determined (both p = 0.007, r = 0.466; p = 0.027, r =-0.391, respectively). No predictor was observed between drug dose and arterial stiffness parameters. Conclusion: Arterial stiffness might be investigated for its potential to reduce CVD risk in patients with BD. Given the established CVD complications in this patient population, further studies are needed to determine whether the results are specific to antipsychotic treatment or BD and to clarify the potential arterial protective effects of mood stabilizers. © 2023 Korean College of Neuropsychopharmacology. All rights reserved.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/12349Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.9758/cpn.22.1009Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorKiliçaslan, Asli Kazgan
dc.contributor.authorEmir, Burcu Sirlier
dc.contributor.authorYildiz, Sevler
dc.contributor.authorKiliçaslan, Gölhan
dc.contributor.authorKurt, Osman
dc.date.accessioned2026-10-18T20:27:15.772782625Z
dc.date.available2026-10-18T20:27:15.772782625Z
dc.date.issued2023
dc.description.abstractObjective: Bipolar disorder (BD) is an inflammatory and metabolic disease. The disease and the drugs used to treat it may affect cardiovascular disease (CVD) risk. The aim of this study is to investigate arterial stiffness in patients with BD and compare them with healthy controls. Methods: Thirty-nine patients with BD type I in remission and 39 healthy control subjects were included in the study. Carotid and femoral artery intima-media thickness (IMT) and arterial thickness parameters were measured by Doppler ultrasonography. Results: The elastic modulus value of the carotid artery was significantly higher in the patients than in the control group (p = 0.015). Although the IMT of both carotid and femoral artery was thicker in patients than in healthy control subjects, this difference was not statistically significant (p = 0.105; p = 0.391). There was a significant positive correlation between chlorpromazine equivalent dose and femoral elastic modulus value (p = 0.021, r = 0.539). There was a positive correlation between lithium equivalent dose and carotid compliance; a significant negative correlation between lithium equivalent dose and carotid elastic modulus was also determined (both p = 0.007, r = 0.466; p = 0.027, r =-0.391, respectively). No predictor was observed between drug dose and arterial stiffness parameters. Conclusion: Arterial stiffness might be investigated for its potential to reduce CVD risk in patients with BD. Given the established CVD complications in this patient population, further studies are needed to determine whether the results are specific to antipsychotic treatment or BD and to clarify the potential arterial protective effects of mood stabilizers. © 2023 Korean College of Neuropsychopharmacology. All rights reserved.
dc.identifier.doi10.9758/cpn.22.1009
dc.identifier.endpage525
dc.identifier.issn1738-1088
dc.identifier.issue3
dc.identifier.scopus2-s2.0-85168739769
dc.identifier.startpage516
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/12349
dc.identifier.volume21
dc.language.isoen
dc.publisherKorean College of Neuropsychopharmacology
dc.relation.ispartofClinical Psychopharmacology and Neuroscience
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectArterial stiffness
dc.subjectBipolar disorder
dc.subjectCardiovascular risks
dc.subjectCarotid intima-media thickness
dc.subjectElastic modulus
dc.subjectFemoral artery
dc.subjectcarbamazepine
dc.subjectchlorpromazine
dc.subjectlithium
dc.subjectmood stabilizer
dc.subjectneuroleptic agent
dc.subjectvalproic acid
dc.subjectadult
dc.subjectarterial wall thickness
dc.subjectartery compliance
dc.subjectArticle
dc.subjectbipolar I disorder
dc.subjectclinical article
dc.subjectcontrolled study
dc.subjectdiastole
dc.subjectDoppler ultrasonography
dc.subjectfemale
dc.subjecthuman
dc.subjectmale
dc.subjectmental patient
dc.subjectremission
dc.subjectsystole
dc.subjectYoung modulus
dc.titleArterial stiffness in patients with bipolar disorder
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus5
rdl.oa.statusgold
rdl.source.indexSCOPUS